Further limitations are the small sample size and the associated lack of significance in statistical analysis of the data and the lack of correlation of resistin levels with tumor size based on T-staging and tumor grading in patients suffering from colon cancer. The gene discussed is RETN; the disease is malignant colon neoplasm.